RPS2P35

Across TCGA pan-cancer cohorts, RPS2P35 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RPS2P35 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS2P35 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS2P35 expression acts as an unfavorable survival marker, although some lineages such as BLCA and COAD show a favorable association.

ACC, LIHC, and BLCA are the cancer types where RPS2P35 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Quartile	All	0.373	0.864	<.001	93	view →
LIHC	DFS	Median	All	0.215	0.388	<.001	90	view →
BLCA	OS	Tertile	All	0.722	0.275	.001	42	view →
UCS	OS	Quartile	All	0.552	0.889	.001	42	view →
COAD	DFS	Median	All	0.777	0.603	.001	40	view →
LUSC	OS	Quartile	All	0.841	0.657	.001	39	view →
LUAD	OS	Tertile	III,IV	0.266	0.678	.003	31	view →
SARC	OS	Tertile	All	0.582	0.861	<.001	24	view →
KIRP	OS	Quartile	All	0.795	0.938	.002	20	view →
CESC	DFS	Quartile	II,III,IV	0.706	0.270	.008	16	view →
MESO	DFS	Tertile	All	0.683	0.315	.019	15	view →
READ	OS	Tertile	IV	0.516	0.924	.010	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

RPS2P35–ACC (OS)

Open the ACC breakdown →